| 1 |
Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study |
|
| | Li Wang, Kegang Jia, Fang Li, Chenxu Zhang, Gang Feng, Jun Du | | | Frontiers in Pharmacology. 2021; 12 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non–Small Cell Lung Cancer: A Meta-Analysis and Systematic Review |
|
| | Jingyi Huang, Zhichao Wang, Han Xue, Ailing Cao, Cassidy Turner, Jing Wang, Li Zhang, Jinghai Wang, Na Xiao, Jie Xu, Xianmei Zhou, Hailang He | | | Frontiers in Pharmacology. 2020; 11 | | | [Pubmed] [Google Scholar] [DOI] | |
|
